Vanguard National Trust’s Repligen RGEN Stock Holding History

Vanguard National Trust’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.5K	Hold	33	–	–	﹤0.01%	662
2026 Q1	$3.89K	Buy	+33	New	+$4.61K	﹤0.01%	623

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard National Trust's RGEN Position: Q2 2026 in Review

Vanguard National Trust held its Repligen (RGEN) position steady in Q2 2026 at 33 shares worth $4.5K. The position accounts for ﹤0.01% of the portfolio, ranked #662.

Vanguard National Trust first reported a position in RGEN in Q1 2026 and has held it in 2 quarters since. 475 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Vanguard National Trust held 33 shares of Repligen worth $4.5K as of Q2 2026.
Vanguard National Trust left its Repligen share count unchanged in Q2 2026.
Repligen made up ﹤0.01% of Vanguard National Trust's portfolio in Q2 2026, its #662 holding.
Vanguard National Trust first reported a position in Repligen in Q1 2026 and has held it in 2 quarters since.
475 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.